Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma.

[1]  Cheng-Ta Yang,et al.  Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines. , 2006, Biochemical and biophysical research communications.

[2]  Hiroyuki Yamamoto,et al.  Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers , 2005, Oncogene.

[3]  B. Ljung,et al.  The gene expression signatures of melanoma progression , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Koch,et al.  The extracellular matrix component WIF-1 is expressed during, and can modulate, retinal development , 2004, Molecular and Cellular Neuroscience.

[5]  Amie Y Lee,et al.  Cloning and characterization of the promoter of human Wnt inhibitory factor-1. , 2004, Biochemical and biophysical research communications.

[6]  J. Behrens,et al.  The Wnt connection to tumorigenesis. , 2004, The International journal of developmental biology.

[7]  Biao He,et al.  Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma , 2004, Oncogene.

[8]  N. Thatcher.  Second Heidelberg Thoracic Oncology Symposium on the Diagnosis and Treatment of Pleural Mesothelioma--introduction. , 2004, Lung cancer.

[9]  Biao He,et al.  Wnt Inhibitory Factor-1 Is Silenced by Promoter Hypermethylation in Human Lung Cancer , 2004, Cancer Research.

[10]  Wei Dong Chen,et al.  Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer , 2004, Nature Genetics.

[11]  T. Kipps,et al.  Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Yvonne Wallis,et al.  The Wnt Antagonist sFRP1 in Colorectal Tumorigenesis , 2004, Cancer Research.

[13]  Biao He,et al.  Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression , 2003, Oncogene.

[14]  Christian Pilarsky,et al.  WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer , 2003, The Journal of pathology.

[15]  Jeffrey D. Axelrod,et al.  A Second Canon , 2003 .

[16]  K. Uematsu,et al.  Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. , 2003, Cancer research.

[17]  Yoshiaki Kawano,et al.  Secreted antagonists of the Wnt signalling pathway , 2003, Journal of Cell Science.

[18]  J. Kim,et al.  Human secreted frizzled-related protein is down-regulated and induces apoptosis in human cervical cancer. , 2002, Experimental cell research.

[19]  Matthias Mann,et al.  Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. , 2002, Genes & development.

[20]  M. Bittner,et al.  Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. , 2002, Cancer cell.

[21]  Xi He,et al.  Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism , 2002, Cell.

[22]  B. Boman,et al.  Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. , 2001, Cancer research.

[23]  F. Chan,et al.  Alterations of frizzled (FzE3) and secreted frizzled related protein (hsFRP) expression in gastric cancer. , 2001, Life sciences.

[24]  D. Birnbaum,et al.  WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type , 2001, Oncogene.

[25]  D. Chung,et al.  Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. , 2001, Cancer research.

[26]  P. Polakis.  Wnt signaling and cancer. , 2000, Genes & development.

[27]  R. Bueno.  Mesothelioma clinical presentation. , 1999, Chest.

[28]  A. Ishimoto,et al.  Characterization of Mouse Dishevelled (Dvl) Proteins in Wnt/Wingless Signaling Pathway* , 1999, The Journal of Biological Chemistry.

[29]  M. Kraus,et al.  Isolation and Biochemical Characterization of the Human Dkk-1 Homologue, a Novel Inhibitor of Mammalian Wnt Signaling* , 1999, The Journal of Biological Chemistry.

[30]  Akira Kikuchi,et al.  DIX Domains of Dvl and Axin Are Necessary for Protein Interactions and Their Ability To Regulate β-Catenin Stability , 1999, Molecular and Cellular Biology.

[31]  C. Albanese,et al.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Kitagawa,et al.  An F‐box protein, FWD1, mediates ubiquitin‐dependent proteolysis of β‐catenin , 1999, The EMBO journal.

[33]  J. Nathans,et al.  A new secreted protein that binds to Wnt proteins and inhibits their activites , 1999, Nature.

[34]  R. Benarous,et al.  The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell , 1999, Current Biology.

[35]  Stephen J. Elledge,et al.  The SCFβ-TRCP–ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro , 1999 .

[36]  S. Sokol,et al.  Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and β-catenin , 1998, Current Biology.

[37]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .

[38]  J. Herndon,et al.  Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. , 1998, Chest.

[39]  F. Luyten,et al.  The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[41]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[42]  Paul Polakis,et al.  Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly , 1996, Science.

[43]  C. Harris,et al.  Asbestos-associated chromosomal changes in human mesothelial cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Rosenberg,et al.  Adoptive immunotherapy of newly induced murine sarcomas. , 1985, Cancer research.

[45]  Harold E. Varmus,et al.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome , 1982, Cell.

[46]  K. Marumo,et al.  Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN‐mutated prostate cancer cells , 2005, The Prostate.

[47]  Amie Y Lee,et al.  A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. , 2004, Neoplasia.

[48]  L. Patthy,et al.  The WIF module. , 2000, Trends in biochemical sciences.